Maluf-Filho F, et al. Transduodenal Endosonography-Guided Biliary Drainage and Duodenal Stenting for Palliation of Malignant Obstructive Jaundice and Duodenal Obstruction. JOP. J Pancreas (Online) 2012 Mar 10; 13(2):210-214.

CASE SERIES

JOP. J Pancreas (Online) 2012 Mar 10; 13(2):210-214.

Transduodenal Endosonography-Guided Biliary Drainage and Duodenal Stenting for Palliation of Malignant Obstructive Jaundice and Duodenal Obstruction

Fauze Maluf-Filho, Felipe Alves Retes, Carla Zanellato Neves, Cezar Fabiano Manabu Sato, Fabio Shiguehissa Kawaguti, Ricardo Jureidini, Ulysses Ribeiro Jr, Telesforo Bacchella

Cancer Institute of São Paulo University Medical School (ICESP). São Paulo, SP, Brazil

ABSTRACT

Context Endosonography-guided biliary drainage has been used over the last few years as a salvage procedure when endoscopic retrograde cholangiopancreatography fails. Malignant gastric outlet obstruction may also be present in these patients. We report the results of both procedures during the same session in patients with duodenal and biliary obstruction due to malignant disease. Methods A retrospective review from a prospective collected database. Results Technical success was achieved in all five patients; however, only three patients experienced relief of jaundice and gastric outlet obstruction. Conclusions Endosonography-guided biliary drainage and duodenal stenting in the same session is feasible. However, severe complications may limit the procedure. This is a challenging procedure and should be done by experts with special attention to patient’s selection.

INTRODUCTION

Endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent placement has become the preferred therapy for biliary drainage in patients with unresectable malignant biliary obstruction or those unfit for surgery [1, 2]. When ERCP fails, patients usually undergo percutaneous transhepatic cholangiography (PTC), which carries higher morbidity rates compared to ERCP. On the other hand, it is usually contraindicated in patients with ascites [3]. Endosonography-guided biliary drainage has been used over the last few years as a salvage procedure [4, 5]. It has a high technical success rate, but also a high complication rate. It is an evolving technique for which the best approach has yet to be determined. There are two possible access routes: transduodenal or extrahepatic [6, 7, 8] and transgastric or intrahepatic [9, 10].

Malignant gastric outlet obstruction may also be present in patients with pancreatic, gastric, duodenal, or metastatic tumors. Surgical bypass or duodenal stenting are the possible palliative options in such cases [11]. A recent multicenter trial comparing both treatments demonstrated the superiority of surgical bypass over duodenal stenting when survival was greater than 2 months [12].

We report the results of transduodenal echo-guided biliary drainage and duodenal stenting performed during the same session in patients with duodenal and biliary obstruction due to malignant disease.

PATIENTS AND METHODS

From September 2010 to April 2011, five patients were referred for palliation of duodenal and biliary obstruction due to malignant disease. Demographic, clinical, laboratory, and radiologic data are shown in Tables 1 and 2.

Table 1. Demographic and clinical data.
Patient	Age	Sex	Tumor	TNM staging	Karnofski Index
#1	46	Female	Colonic adenocarcinoma	T4N1M+	100
#2	66	Female	Cervix squamous cell cancer	T4N1M+	80
#3	72	Female	Pancreatic adenocarcinoma	T4N1M+	60
#4	88	Male	Pancreatic adenocarcinoma	T4N1M+	70
#5	78	Male	Pancreatic adenocarcinoma	T4N1M+	60

Table 2. Gastric outlet obstruction score and laboratory and endosonography findings.
Patient	Total/direct bilirubin levels (mg/dL)	Common bile duct diameter^a	Largest left intrahepatic branch^a	Gastric outlet obstruction score ^b	Ascites
#1	9/7	25 mm	4 mm	1: liquids/thickened liquids	Yes
#2	10/8	18 mm	3 mm	1: liquids/thickened liquids	Yes
#3	30/24	20 mm	3 mm	1: liquids/thickened liquids	Yes
#4	14/4	22 mm	4 mm	0: no/inadequate oral intake	Yes
#5	33/25	25 mm	5 mm	0: no/inadequate oral intake	Yes
^a Evaluated by endosonography ^b Gastric outlet obstruction score. 0: no/inadequate oral intake; 1: liquids/thickened liquids; 2: semisolids/low residue diet; 3: unmodified diet [13]

Upper endoscopy had previously shown duodenal stenosis due to circumferential ulcerated and infiltrative lesions in all cases. Facing a high probability of an unsuccessful ERCP, we discussed the possibility of endosonography-guided biliary drainage and duodenal stenting with the surgical and oncological teams. We performed the procedure following the same sequence in all cases. For the whole procedure, the patient was under general anesthesia and fluoroscopic guidance was used. A therapeutic duodenoscope (TJF-160, Olympus, Tokyo, Japan) was introduced and advanced until the duodenal bulb. A 0.035 guidewire (Jagwire^®, Boston Scientific, Natick, MA, USA) was advanced through the duodenal stenosis until the proximal jejunum (Figure 1). The stenosis was dilated with a dilation balloon (CRE^TM Balloon Dilator, Boston Scientific, Natick, MA, USA) until 15 mm. The duodenoscope was advanced but the major ampulla could not be identified. The guidewire was left in place and the duodenoscope was removed. A linear array echoendoscope (GF UCT-140, Olympus, Tokyo, Japan; Alfa 5 processor, Aloka, Tokyo, Japan) was introduced. Endosonography examination was performed to look for the dilated common bile duct, the largest left intrahepatic duct and the presence of collateral veins. In all cases, the largest left intrahepatic ducts were smaller than 6 mm and we did not attempt the antegrade transhepatic access. The common bile duct was punctured with a 19-gauge needle (EUSN-19T, Cook Medical, Bloomington, IN, USA) (Figure 2). Bile was aspirated and contrast was injected to confirm an adequate position of the needle (Figure 3). After confirmation with fluoroscopy, a 0.035 guidewire (Jagwire^®, Boston Scientific, Natick, MA, USA) was advanced through the needle into the common bile duct and the needle was retrieved. A 6-Fr cystotome (Endo Flex, Voerde, Germany) was then inserted over the guidewire to create a bilioenteric communication (Figure 4). In four patients, a partially covered biliary self-expandable metallic stent (WallFlex^® 60/100 mm, Boston Scientific, Natick, MA, USA) was inserted into the common bile duct and successfully deployed, creating a choledochoduodenal fistula (Figure 5). In one patient (Patient#2), we deployed an uncovered biliary metallic stent (WallFlex^® 60/100 mm, Boston Scientific, Natick, MA, USA). The echoendoscope was removed and the duodenoscope was introduced over the duodenal guidewire. A non-covered duodenal self-expandable metallic stent (WallFlex^® 120/220 mm, Boston Scientific, Natick, MA, USA) was inserted over the guidewire and deployed in all patients (Figures 6 and 7).

Figure 1. Duodenal stenosis.

Figure 2. Common bile duct punction.

Figure 3. Contrast injection.

Figure 4. Biliary and duodenal guide-wires.

Figure 5. Deployed biliary stent.

Figure 6. Deployed biliary and duodenal stents.

Figure 7. Deployed biliary and duodenal stents (X-ray).

ETHICS

These patients were not part of research protocol. Their cases were discussed in a multidisciplinary round and because of their clinical conditions, the endoscopic approach was chosen. They signed the informed consent after complete explanation of the procedure and its possible complications.

RESULTS

Deployment of both biliary and duodenal stents was technically successful in all cases. However, only three patients experienced relief of jaundice and gastric outlet obstruction. Of those patients, only two were discharged from the hospital. Three patients died from direct or indirect endosonography-guided biliary drainage related complications (Table 3).

Table 3. Clinical results of endosonography-guided biliary drainage and duodenal stenting.
Patient	Total/direct bilirubin levels (mg/dL)		Immediate complication	Gastric outlet obstruction score	Follow-up
Patient	24 h	72 h	30 days after procedure		Follow-up
#1	3/2	2/1.7	None	2: semisolids/low residue diet	Duodenoenteric fistula 16 days after the procedure (Figure 8). A second duodenal stent was deployed with fistula occlusion. Died 3 months later
#2	10/9	7/6.5	Biliary fistula^a Laparotomy 2days after the procedure	-	Died 17days after the procedure
#3	14/10	9/5	None	0: no/inadequate oral intake	Died 2 months later
#4	22/19	19/17	Cardiogenic shock (immediate post-procedure)	-	Died 4 days after the procedure
#5	18/10	6/4	None	-	Died 15 days after the procedure Pneumonia and sepsis
^a Uncovered biliary stent

Figure 8. Duodenoenteric fistula.

DISCUSSION

ERCP with placement of self-expandable metal stents is the gold standard for palliation of malignant biliary obstruction [1, 2]. However, when the tumor involves the duodenum, duodenal balloon dilatation is usually attempted to allow endoscope passage and, eventually, major ampulla cannulation [14]. If this is not the case, PTC usually is the next step. However, PTC carries a higher complication rate and involves the use of external biliary drains [3]. Moreover, PTC does not relieve duodenal obstruction.

Recently, endosonography-guided biliary drainage has emerged as an alternative for cases when ERCP fails [6]. For those patients with combined biliary and duodenal obstruction, endosonography-guided biliary drainage enables deployment of duodenal and biliary stents in a single procedure and avoids the risk of duodenal perforation during duodenal balloon dilatation [15, 16]. Endosonography-guided biliary drainage was first described by Giovannini [6] and later by many others [5, 7, 8, 9, 10]. Since then, over 300 cases have been reported using transgastric and transduodenal routes. Reported technical success rates are high (75-100%) [4].

We report a case series of 5 patients who presented with metastatic cancer causing both biliary and duodenal obstruction. Duodenal balloon dilation and direct access to the major ampulla proved unsuccessful in all patients. Despite the technical success of endosonography-guided biliary drainage and duodenal stenting in all patients, just three patients (60%) experienced relief from biliary and duodenal obstruction. One patient developed pneumonia related sepsis and died 15 days after the endoscopic procedure. The remaining two patients did not experience significant improvement of the biliary obstruction. In one patient, an immediate biliary leakage occurred, most likely caused by the inadequate choice of an uncovered biliary stent. It is possible that the presence of ascites in the subhepatic space prevented adequate adherence between the duodenal and common bile duct walls, predisposing the patient to this complication. The remaining patient developed cardiogenic shock in the immediate post procedural period probably due to myocardial infarction. The fall in serum bilirubin levels was very discrete and the patient died of irreversible shock 4 days later.

Severe complications are the main limitations of endosonography-guided biliary drainage and include bile leakage, pneumoperitoneum, hemorrhage, and cholangitis. The reported complication rates vary from 10 to 36% [4]. Our impression was that these rates probably reflected the learning curve of one of the most complex therapeutic endoscopic procedures, where expertise in both ERCP and endosonography is necessary. It is also recognized that the lack of dedicated wires, catheters, needles, and stents might contribute to the complexity of the procedure. However, based on the present series, biliary and duodenal adequate positioning and deployment of metallic stents in a single session did not prove to be overly challenging. Actually, it proved possible in all patients. In the present series, all procedures were performed by a senior endoscopist experienced both in ERCP and curved-array endosonography for 15 years. Except for the case where the choice for an inadequate model of stent (uncovered biliary stent) lead to a complication (biliary leakage), the unfavorable clinical evolution possibly reflected the importance of patient selection on results. In the present series, all patients presented with stage IV disease with ascites. It is also noteworthy that three patients were in their 8^th or 9^th decades of life and were clinically compromised as suggested by their low Karnofsky index scores.

A recent study favored surgical treatment of gastric outlet obstruction compared to metallic stenting, especially for patients with life expectancies longer than 3 months [12]. This was a concern in our series as clinical assessment and oncologic staging suggested shorter life expectancies. In fact, the indication for endosonography-guided biliary drainage was a decision of a multidisciplinary team, which included radiologists who found PTC to be unsafe due to the presence of ascites in all the patients of the present series.

Obviously, this small clinical series does not allow any conclusions to be drawn. However, it suggests that elder patients with stage IV cancer, ascites, and low clinical performance status scores are at higher risk for clinical failure of single session endosonography-guided biliary drainage and duodenal stenting, despite the technical success of the procedures. As clinical experience with endosonography-guided biliary drainage increases, further studies utilizing this challenging technique should address technical aspects, new devices, and patient selection.

Received January 13^th, 2012 - Accepted January 23^rd, 2012

Key words Bile Ducts /ultrasonography; Drainage /adverse effects /methods; Duodenal Obstruction; Endosonography; Gastric Outlet Obstruction; Jaundice, Obstructive

Abbreviations ERCP: endoscopic retrograde cholangiopancreatography; PTC: percutaneous transhepatic cholangiography

Conflict of interest The authors have no potential conflict of interest

Correspondence
Fauze Maluf-Filho
Instituto do Câncer do Estado de São Paulo
Avenida Doutor Arnaldo, 251; Cerqueira César
CEP: 01246-000
São Paulo, SP
Brazil
Phone: +55-11.3893.2000
Fax: 55-11.3893.2000
E-mail: fauze.maluf@terra.com.br

References

1. Stern N, Sturgess R. Endoscopic therapy in the management of malignant biliary obstruction. Eur J SurgOncol2008; 34(3):313-317 (More details: [1]).

2. Cipolletta L, Rotondano G, Marmo R, Bianco MA. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review. Dig Liver Dis 2007; 39(4):375-88 (More details: [2]).

3. Winick AB, Waybill PN, Venbrux AC. Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol 2001; 4(3):200-6 (More details: [3]).

4. Perez-Miranda M, Serna C, Diez-Redondo P, Vila JJ. Endosonography-guided cholangiopancreatography as a salvage drainage procedure for obstructed biliary and pancreatic ducts. World J GastrointestEndosc2010; 2(6):212-222 (More details: [4]).

5. Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P. Interventional EUS-guided cholangiography: evaluation of a technique in evolution. Gastrointest Endosc 2006; 64:53-9 (More details: [5]).

6. Giovannini M, Moutardier V, Pesenti C, Bories E, Lelong B, Delpero JR. Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy 2001; 33(10):898-900 (More details: [6]).

7. Itoi T, Itokawa F, Sofuni A, Kurihara T, Tsuchiya T, Ishii, et al. Endoscopic ultrasound-guided choledochoduodenostomy in patients with failed endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2008; 14(39):6078-82 (More details: [7]).

8. Yamao K, Bhatia V, Mizuno N, SawakiA, Ishikawa H, Tajika M, et al. EUS-guided choledochoduodenostomy for palliative biliary drainage in patients with malignant biliary obstruction: results of long-term follow-up. Endoscopy 2008; 40:340-2 (More details: [8]).

9. Giovannini M, Dotti M, Bories E, Moutardoer V, Pesenti C, Danisi C, Delpero JR. Hepaticogastrostomy by echo-endoscopy as a palliative treatment in a patient with metastatic biliary obstruction. Endoscopy 2003; 35:1076-8 (More details: [9]).

10. Artifon ELA, Chaves DM, Ishioka S, Souza TF, Matuguma SE, Sakai P. Echoguieded hepatico-gastrostomy: a case report. Clinics (Sao Paulo) 2007; 62:799-802 (More details: [10]).

11. Ly J, O'Grady G, Mittal A, Plank L, Windsor JA. A systematic review of methods to palliate malignant gastric outlet obstruction. Surg Endosc 2010; 24(2):290-7 (More details: [11]).

12. Jeurnink SM, Steyeberg EW, Van Hooft JE, Van Eijck CH, Schwartz MP, Vleggaar FP, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc2010; 71(3):490-9 (More details: [12]).

13. Adler GG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents:experience in 36 patients. Am J Gastroenterol 2002; 97(1):72-8 (More details: [13]).

14. Kikuyama M, Itoi T, Sasada Y, Sofuni A, Ota Y, Itokawa F. Large-balloon technique for one-step endoscopic biliary stenting in patients with an inaccessible major papila owing to difficult duodenal stricture. Gastrointest Endosc 2009; 70(3):568-72. (More details: [14]).

15. Iwamuro M, Kawamoto H, Harada R, Kato H, Hirao K, Mizuno O, et al. Combined duodenal stent placement and endoscopic ultrasonography-guided biliary drainage for malignant duodenal obstruction with biliary stricture. Dig Endosc2010; 22(3):236-40 (More details: [15]).

16. Maire F, Hammel P, Ponst P, Aubert A, O'Toole D, Hentic O, et al. Long-term outcomes of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol2006; 101(4):735-42 (More details: [16]).